Most people who take vitamin D3 are only doing half the job. They’ve read the headlines about deficiency, picked up a bottle, and assumed that’s enough. But there’s a critical piece of the puzzle that rarely gets mentioned — and without it, the calcium that D3 helps your body absorb has nowhere safe to go.
That piece is Vitamin K2.
This isn’t a marketing claim. It’s biochemistry — and the research behind it is compelling enough that a growing number of clinicians now consider D3 and K2 inseparable.
What Vitamin D3 Actually Does
Vitamin D3 (cholecalciferol) is the form of vitamin D your skin produces when exposed to UVB sunlight. Its primary role in the body is to dramatically increase calcium absorption in the gut — research published in the American Journal of Clinical Nutrition found that optimal vitamin D status can increase intestinal calcium absorption by up to 65% compared to deficient levels [1].
For anyone living in the UK, this matters enormously. UVB levels between October and April are too low to trigger meaningful D3 synthesis in the skin, meaning the majority of the population enters spring with depleted stores. Public Health England has acknowledged this, recommending supplementation throughout the autumn and winter months — though many nutrition researchers argue the recommended 400IU falls significantly short of what’s needed to maintain optimal blood levels [2].
The result is that millions of people are supplementing with D3 — but very few are thinking about what happens to the calcium that D3 mobilises.
The Problem: Calcium Without Direction
Here’s where things get important. Vitamin D3 increases calcium in the bloodstream. But calcium doesn’t automatically know where to go. The body needs specific proteins to direct calcium into bone and, equally importantly, to keep it out of soft tissues like arteries, kidneys and joints.
When those proteins aren’t activated, calcium can deposit in blood vessel walls — a process called vascular calcification. This is not a theoretical concern. Research published in the Journal of Nutritional Science has identified uncontrolled vascular calcification as an independent risk factor for cardiovascular disease [3].
The proteins responsible for preventing this are osteocalcin and Matrix Gla Protein (MGP). Both require one thing to function: Vitamin K2.
What K2 Does That K1 Cannot
Vitamin K is often misunderstood as a single nutrient. In reality, K1 (phylloquinone) and K2 (menaquinone) are functionally distinct.
K1, found in leafy greens, is primarily directed to the liver where it supports blood clotting. K2, found in fermented foods and certain animal products, is directed to bone and vascular tissue — precisely where calcium management is most critical.
A landmark study published in the Journal of Nutrition — the Rotterdam Study — followed nearly 5,000 adults over 10 years and found that higher dietary K2 intake was associated with significantly reduced coronary calcification, cardiovascular mortality, and all-cause mortality. K1 intake showed no such association [4].
This distinction matters when choosing a supplement. K2 is the form that activates the calcium-directing proteins D3 depends on.
MK-7 vs MK-4: Why the Form of K2 Matters
Not all K2 is equal. It comes in multiple forms, called menaquinones, with MK-4 and MK-7 being the most studied.
The critical difference is half-life. MK-4 has a biological half-life of approximately 1–2 hours, meaning it clears the bloodstream rapidly and would require multiple doses throughout the day to maintain activity. MK-7, particularly from natural fermentation sources, has a half-life of approximately 72 hours — meaning a single daily dose maintains stable blood levels throughout the day and night [5].
A clinical trial published in Osteoporosis International confirmed that MK-7 supplementation at 180µg daily for three years significantly improved bone strength and reduced bone loss in postmenopausal women compared to placebo [6].
For anyone taking a once-daily supplement, MK-7 is the superior form.
The Arterial Calcification Connection
The protein MGP (Matrix Gla Protein) is produced by smooth muscle cells in blood vessel walls. Its entire purpose is to prevent calcium from accumulating in arterial tissue. But MGP only works when it has been carboxylated — activated — by Vitamin K2.
When K2 is insufficient, MGP remains in its inactive form (ucMGP). Research published in Atherosclerosis found that elevated levels of ucMGP are directly associated with increased arterial stiffness and cardiovascular risk — and that K2 supplementation measurably reduced ucMGP levels [7].
In practical terms: if you’re taking high-dose D3 without K2, you’re increasing calcium absorption without ensuring the mechanism that keeps calcium out of your arteries is switched on.
Who Is Most at Risk
Certain groups are particularly likely to be low in both D3 and K2 simultaneously:
- UK residents generally — insufficient UVB for D3 synthesis for roughly six months of the year, combined with low fermented food consumption (the primary dietary K2 source).
- People over 60 — skin’s capacity to synthesise D3 from sunlight declines significantly with age, and dietary K2 intake tends to fall as appetites reduce.
- Those following plant-based diets — few plant foods contain meaningful K2, and D3 from sunlight is the primary source. Vegan D3 supplements derived from lichen are available and equally effective.
- Darker skin tones — melanin reduces UVB absorption, meaning D3 synthesis is significantly less efficient at UK latitudes regardless of sun exposure.
What to Look for in a D3 + K2 Supplement
Given how many products are on the market, these are the factors that actually matter:
- D3, not D2. Cholecalciferol (D3) is substantially more effective at raising and maintaining blood 25(OH)D levels than ergocalciferol (D2). A meta-analysis in the American Journal of Clinical Nutrition confirmed D3 is approximately 87% more potent in raising serum vitamin D [8].
- MK-7 form of K2. Look for “menaquinone-7” on the label. Naturally fermented MK-7 is preferable to synthetic versions for stability and bioavailability.
- Meaningful doses. Research-supported doses are typically 2,000–4,000IU of D3 and 100–200µg of K2 MK-7 daily for healthy adults. The NHS’s 400IU recommendation is a minimum floor for preventing deficiency, not a target for maintaining optimal levels.
- GMP manufacturing. The UK supplement industry is lightly regulated. Good Manufacturing Practice (GMP) certification means the facility has been independently audited for quality control, accurate labelling and contamination prevention.
- Vegan D3 if relevant. Most D3 is lanolin-derived (from sheep’s wool). Vegan D3 from lichen is functionally identical but suitable for plant-based and halal diets.
The Bottom Line
Vitamin D3 is one of the most important supplements you can take, particularly in the UK. But supplementing D3 without K2 is an incomplete intervention — you’re raising calcium absorption without ensuring that calcium is properly directed.
The combination of D3 and K2 MK-7 is supported by a coherent body of mechanistic and clinical evidence. It isn’t a trend. It’s how these nutrients were always meant to work together.
If you’re already taking D3, check whether your supplement includes K2 MK-7. If it doesn’t, it’s worth making the switch.
References
- Heaney RP, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003.
- Cashman KD, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016.
- Lanzer P, et al. Medial vascular calcification revisited. Eur Heart J. 2014.
- Geleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease. J Nutr. 2004.
- Schurgers LJ, et al. Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007.
- Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013.
- Cranenburg EC, et al. Circulating matrix Gla protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome. J Thromb Haemost. 2011.
- Tripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status. Am J Clin Nutr. 2012.
About the author: Abdul Khalieq is the Founder and Director of Nutrivity Ltd, a UK supplement brand that has served over 300,000 customers since 2017. Nutrivity specialises in high-strength, vegan friendly and halal friendly supplements, GMP manufactured in the UK. Their Vitamin D3 K2 supplement UK provides 4000IU D3 and 100µg MK-7 K2 in a single daily vegan tablet — a full year’s supply.
